Advertisement
Advertisement
LUCD
Lucid Diagnostics Inc. Common Stock
1.16
USDSponsored
+0.01
+0.43%
Apr 10, 13:55 UTC -4
Open
LUCD Earnings Reports
Positive Surprise Ratio
LUCD beat 8 of 18 last estimates.
44%
Next Report
Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
$1.41M
/-$0.08
Implied change from Q4 25 (Revenue/ EPS)
-6.49%
/-20.00%
Implied change from Q1 25 (Revenue/ EPS)
+69.85%
/-84.62%
Lucid Diagnostics Inc. Common Stock earnings per share and revenue
On Mar 25, 2026, LUCD reported earnings of -0.10 USD per share (EPS) for Q4 25, beating the estimate of -0.10 USD, resulting in a 1.96% surprise. Revenue reached 1.50 million, compared to an expected 1.39 million, with a 8.40% difference. The market reacted with a -4.00% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 8 analysts forecast an EPS of -0.08 USD, with revenue projected to reach 1.41 million USD, implying an decrease of -20.00% EPS, and decrease of -6.49% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
FAQ
What were Lucid Diagnostics Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Lucid Diagnostics Inc. Common Stock reported EPS of -$0.10, beating estimates by 1.96%, and revenue of $1.50M, 8.4% above expectations.
How did the market react to Lucid Diagnostics Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -4%, changed from $1.25 before the earnings release to $1.20 the day after.
When is Lucid Diagnostics Inc. Common Stock expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for Lucid Diagnostics Inc. Common Stock's next earnings report?
Based on 8
analysts, Lucid Diagnostics Inc. Common Stock is expected to report EPS of -$0.08 and revenue of $1.41M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement